It has been reported that the nuclear translocation of TFEB is inhibited by mTOR activation, and inhibition of mTOR activity could promote TFEB nuclear translocation to protect podocyte injury in DN (Martina et al., 2012; Zhao et al., 2018). Here, MTOR is linked to liver dysplastic nodule.